Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mu-type opioid receptor | ||
Ligand | BDBM50140745 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_148227 | ||
Ki | 2165±n/a nM | ||
Citation | Chen, Z; Goehring, RR; Valenzano, KJ; Kyle, DJ Design and synthesis of novel small molecule N/OFQ receptor antagonists. Bioorg Med Chem Lett14:1347-51 (2004) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mu-type opioid receptor | |||
Name: | Mu-type opioid receptor | ||
Synonyms: | M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 44789.51 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P35372 | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM50140745 | |||
n/a | |||
Name | BDBM50140745 | ||
Synonyms: | (3aR,7aR)-1-Ethyl-3-[1-(4-propyl-cyclohexyl)-piperidin-4-yl]-octahydro-benzoimidazol-2-one | CHEMBL282376 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H41N3O | ||
Mol. Mass. | 375.5911 | ||
SMILES | CCCC1CCC(CC1)N1CCC(CC1)N1[C@@H]2CCCC[C@H]2N(CC)C1=O |wU:21.24,wD:16.17,(.75,-13.1,;.33,-11.62,;1.41,-10.51,;1,-9.03,;-.5,-8.65,;-.92,-7.16,;.16,-6.04,;1.66,-6.42,;2.08,-7.93,;-.26,-4.55,;-1.75,-4.16,;-2.16,-2.69,;-1.07,-1.59,;.4,-1.99,;.82,-3.47,;-1.48,-.12,;-2.94,.37,;-4.27,-.4,;-5.61,.37,;-5.61,1.9,;-4.27,2.67,;-2.94,1.9,;-1.48,2.37,;-1,3.84,;.5,4.15,;-.57,1.12,;.96,1.11,)| | ||
Structure |